Publikationen von Galldiks, Norbert

Le Rhun, Emilie, Devos, Patrick , Winklhofer, Sebastian, Lmalem, Hafida, Brandsma, Dieta, Kumthekar, Priya, Castellano, Antonella , Compter, Annette, Dhermain, Frederic, Franceschi, Enrico, Forsyth, Peter, Furtner, Julia, Galldiks, Norbert, Gállego Pérez-Larraya, Jaime, Gempt, Jens, Hattingen, Elke, Hempel, Johann Martin, Lukacova, Slavka, Minniti, Giuseppe, O’Brien, Barbara, Postma, Tjeerd J, Roth, Patrick , Rudà, Roberta, Schaefer, Niklas , Schmidt, Nils O, Snijders, Tom J, Thust, Steffi , van den Bent, Martin , van der Hoorn, Anouk , Vogin, Guillaume , Smits, Marion , Tonn, Joerg C, Jaeckle, Kurt A, Preusser, Matthias , Glantz, Michael, Wen, Patrick Y, Bendszus, Martin und Weller, Michael (2022) Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort. Neuro-Oncology 24 (10), S. 1726-1735. Volltext nicht vorhanden.

Meißner, Anna-Katharina, Gutsche, Robin, Galldiks, Norbert, Kocher, Martin, Jünger, Stephanie T, Eich, Marie-Lisa, Montesinos-Rongen, Manuel, Brunn, Anna, Deckert, Martina, Wendl, Christina, Dietmaier, Wolfgang, Goldbrunner, Roland, Ruge, Maximilian I, Mauch, Cornelia, Schmidt, Nils-Ole , Proescholdt, Martin, Grau, Stefan und Lohmann, Philipp (2021) Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases. Neuro-Oncology 24 (8), S. 1331-1340. Volltext nicht vorhanden.

Kebir, Sied, Schaub, Christina, Junold, Nina, Hattingen, Elke , Schäfer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Galldiks, Norbert , Weller, Johannes , Mack, Frederic, Tzaridis, Theophilos, Bähr, Oliver, Seidel, Clemens, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Borchers, Christian, Tabatabai, Ghazaleh , Hänel, Mathias, Sabel, Michael, Gerlach, Rüdiger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Glas, Martin und Herrlinger, Ulrich (2019) Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial. Journal of Neuro-Oncology 144 (3), S. 501-509. Volltext nicht vorhanden.

Weller, Johannes , Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Hau, Peter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh , Brehmer, Stefanie, Bullinger, Lars, Galldiks, Norbert , Schaub, Christina, Kebir, Sied, Stummer, Walter, Simon, Matthias, Fimmers, Rolf, Coch, Christoph, Glas, Martin, Herrlinger, Ulrich und Schäfer, Niklas (2019) Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial. The Lancet Oncology 20 (10), S. 1444-1453. Volltext nicht vorhanden.

Herrlinger, Ulrich, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Sabel, Michael, Hau, Peter , Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh , Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert , Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schäfer, Niklas, Kebir, Sied, Weller, Johannes , Schaub, Christina, Stummer, Walter, Tonn, Jörg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang , Weller, Michael , Fimmers, Rolf, Schmid, Matthias , Hattingen, Elke , Pietsch, Torsten, Coch, Christoph und Glas, Martin (2019) Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial. The Lancet 393 (10172), S. 678-688. Volltext nicht vorhanden.

Hutterer, Markus , Ebner, Yvonne, Riemenschneider, Markus J., Willuweit, Antje , McCoy, Mark, Egger, Barbara, Schröder, Michael, Wendl, Christina, Hellwig, Dirk, Grosse, Jirka, Menhart, Karin, Proescholdt, Martin, Fritsch, Brita, Urbach, Horst, Stockhammer, Guenther, Roelcke, Ulrich, Galldiks, Norbert , Meyer, Philipp T., Langen, Karl-Josef , Hau, Peter und Trinka, Eugen (2016) Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18 F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic. Journal of Nuclear Medicine 58 (1), S. 129-137. Volltext nicht vorhanden.

Wick, Wolfgang, Roth, Patrick , Hartmann, Christian, Hau, Peter, Nakamura, Makoto, Stockhammer, Florian , Sabel, Michael C., Wick, Antje, Koeppen, Susanne, Ketter, Ralf, Vajkoczy, Peter, Eyupoglu, Ilker, Kalff, Rolf, Happold, Caroline, Galldiks, Norbert, Schmidt-Graf, Friederike, Bamberg, Michael, Reifenberger, Guido, Platten, Michael, von Deimling, Andreas , Meisner, Christoph , Wiestler, Benedikt und Weller, Michael (2016) Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide. Neuro-Oncology, now133. Volltext nicht vorhanden.

Schliesser, Maximilian Georg, Claus, Rainer, Hielscher, Thomas, Grimm, Christiane, Weichenhan, Dieter, Blaes, Jonas, Wiestler, Benedikt, Hau, Peter, Schramm, Johannes, Sahm, Felix, Weiß, Elisa K., Weiler, Markus, Baer, Constance, Schmidt-Graf, Friederike, Schackert, Gabriele, Westphal, Manfred, Hertenstein, Anne, Roth, Patrick , Galldiks, Norbert, Hartmann, Christian, Pietsch, Torsten, Felsberg, Jörg, Reifenberger, Guido, Sabel, Michael Christoph, Winkler, Frank, von Deimling, Andreas , Meisner, Christoph, Vajkoczy, Peter, Platten, Michael , Weller, Michael, Plass, Christoph und Wick, Wolfgang (2016) Prognostic relevance of miRNA-155 methylation in anaplastic glioma. Oncotarget 7 (50). Volltext nicht vorhanden.